Neurodevelopmental origin of cognitive impairment in schizophrenia

被引:101
|
作者
Bora, E. [1 ,2 ]
机构
[1] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Melbourne, Vic 3010, Australia
[2] Melbourne Hlth, Melbourne, Vic, Australia
关键词
Cognition; cognitive reserve; neurodevelopment; psychosis; schizophrenia; METABOLIC SYNDROME; NEGATIVE SYMPTOMS; 1ST-EPISODE SCHIZOPHRENIA; EXECUTIVE FUNCTIONS; POSTONSET PERIOD; OLDER-ADULTS; DEFICITS; CHILDHOOD; PSYCHOSIS; RESERVE;
D O I
10.1017/S0033291714001263
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Cognitive impairment is a common feature of schizophrenia; however, its origin remains controversial. Neurodevelopmental abnormalities clearly play a role in pre-morbid cognitive dysfunction in schizophrenia, yet many authors believe that schizophrenia is characterized by illness-related cognitive decline before and after onset of the psychosis that can be the result of neurodegenerative changes. The main reasons behinds such arguments include, first, the evidence showing that effect sizes of the cognitive deficits in subjects who develop adult schizophrenia gradually increase in the first two decades of life and, second, the fact that there is functional decline in many patients with schizophrenia over the years. In this Editorial, I argue that current evidence suggests that illness-related cognitive impairment is neurodevelopmental in origin and characterized by slower gain (developmental lag) but not cognitive decline continuing throughout the first two decades of life. I introduce a model suggesting that neurodevelopmental abnormality can in fact explain the course of cognitive dysfunction and variations in the trajectory of functional decline throughout the life in individuals with schizophrenia. In this model, the severity of underlying neurodevelopmental abnormality determines the age that cognitive deficits first become apparent and contributes to the cognitive reserve of the individual. Interaction of neurodevelopmental abnormality with clinical symptoms, especially negative symptoms and aging, vascular changes, psychological and iatrogenic factors contributes to the heterogeneity of the functional trajectory observed in this disorder.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: A neurodevelopmental animal model of schizophrenia
    Ozawa, K
    Hashimoto, K
    Kishimoto, T
    Shimizu, E
    Ishikura, H
    Iyo, M
    BIOLOGICAL PSYCHIATRY, 2006, 59 (06) : 546 - 554
  • [42] Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review
    Zoupa, Elli
    Bogiatzidou, Olympia
    Siokas, Vasileios
    Liampas, Ioannis
    Tzeferakos, Georgios
    Mavreas, Venetsanos
    Stylianidis, Stelios
    Dardiotis, Efthimios
    NEUROLOGY INTERNATIONAL, 2023, 15 (01): : 12 - 23
  • [43] Thalamocortical Functional Connectivity, Cognitive Impairment, and Cognitive Remediation in Schizophrenia
    Woodward, Neil D.
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2017, 2 (04) : 307 - 309
  • [44] Senile degeneration and cognitive impairment in chronic schizophrenia
    Dwork, AJ
    Susser, ES
    Keilp, J
    Waniek, C
    Liu, DM
    Kaufman, M
    Zemishlany, Z
    Prohovnik, I
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (11): : 1536 - 1543
  • [45] Eosinophils and Cognitive Impairment in Schizophrenia: A New Perspective
    Obeagu, Emmanuel Ifeanyi
    Bluth, Martin H.
    JOURNAL OF BLOOD MEDICINE, 2024, 15 : 227 - 237
  • [46] Recent advances in treating cognitive impairment in schizophrenia
    Cherrie Galletly
    Psychopharmacology, 2009, 202 : 259 - 273
  • [47] Cognitive Impairment in Schizophrenia: Characteristics, Assessment, and Treatment
    Fatemi, S. Hossein
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (03) : E387 - E387
  • [48] Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
    Robert A. McCutcheon
    Richard S. E. Keefe
    Philip K. McGuire
    Molecular Psychiatry, 2023, 28 : 1902 - 1918
  • [49] Neurotropic Infectious Agents and Cognitive Impairment in Schizophrenia
    Nimgaonkar, Vishwajit L.
    Yolken, Robert H.
    SCHIZOPHRENIA BULLETIN, 2012, 38 (06) : 1135 - 1136
  • [50] The effect of quetiapine in improving cognitive impairment in schizophrenia
    Purdon, SE
    Hellewell, JS
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 118 - 118